| J0897 | Injection, denosumab, 1 mg | 14,160 | $20 | $254.9K |
| J9271 | Injection, pembrolizumab, 1 mg | 5,800 | $40 | $243.6K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 920 | $80 | $71.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 590 | $100 | $56.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 440 | $120 | $50.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 320 | $140 | $45.6K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,700 | $20 | $39.1K |
| Q5116 | Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg | 1,980 | $20 | $33.7K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 80 | $170 | $13.1K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 220 | $60 | $11.8K |